Amr El-Refaey/LinkedIn
Jul 15, 2025, 18:14
Amr El-Refaey: EU Market Share of Biosimilars Approved in Oncology Indications
Amr El-Refaey, Medical Affairs and New Therapy Areas Lead at the Globalpharma LLC, shared a post on LinkedIn:
“EU Market Share of Biosimilars Biosimilars Oncology Indications as a share of the total market!
Click, Zoom and Enjoy!”
Learn more about biosimilars on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 15, 2025, 19:27
Jul 15, 2025, 19:09
Jul 15, 2025, 19:08
Jul 15, 2025, 18:52
Jul 15, 2025, 18:52
Jul 15, 2025, 18:31